Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: HPV After chemoRadioTherapy
A recruiting clinical trial at General University Hospital, Prague, studying HPV and cell-free DNA in patients with recurrent cervical cance…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Ivonescimab in People With Endometrial and Cervical Cancers [Phase 2]
Phase 2 clinical trial investigating Ivonescimab in patients with endometrial cancer and cervical cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening [NA]
Completed clinical trial update evaluating an evidence-based approach to empower Asian American women in cervical cancer screening.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating Volrustomig as monotherapy or in combination with anti-cancer agents across multiple advanced/metastatic…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 [Phase 1]
Phase 1/1b trial evaluating RNDO-564 as a single agent or in combination with pembrolizumab in bladder cancer and nectin-4–associated solid …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Self-sampling for Non-attenders to Cervical Cancer Screening [NA]
A clinical trial in the Czech Republic is evaluating self-sampling methods to improve cervical cancer screening uptake among non-attenders, …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies [Phase 2]
This Phase 2 clinical trial is evaluating Reiki therapy to improve symptoms associated with brachytherapy in gynecologic cancers. The study …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors [Phase 1]
Open-label Phase 1 study evaluating BL-M07D1 in HER2-expressing malignant solid tumors, with recruitment across several tumor types includin…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations [Phase 1, Phase 2]
Phase 1/2 trial of TER-2013 in solid tumors harboring AKT/PI3K/PTEN alterations is currently recruiting to assess safety and preliminary eff…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors [Phase 1]
Phase 1 clinical trial update evaluating the safety and tolerability of the radiopharmaceutical 212Pb-DOTAM-GRPR1 in adults with recurrent o…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Game Changers for Cervical Cancer Prevention [NA]
This clinical trial update reports an ongoing study related to cervical cancer prevention, currently listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer [NA]
This clinical trial update describes a study comparing liquid-based cytology with molecular screening to detect precursor cervical lesions a…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Clinical trial update on paclitaxel therapeutic drug monitoring in cancer patients; the study is currently suspended.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports that GI Innovation is studying GI-101 and GI-101A as single agents or in combination with pembrolizumab o…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer [Phase 2, Phase 3]
This clinical trial update describes an ongoing Phase 2/Phase 3 study comparing PD-1 inhibitors versus PD-L1 inhibitors, each with chemother…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial [NA]
A clinical trial update describing the IMPACT HPV trial assessing interpersonal communication training and vaccination workflow training in …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI [NA]
Michigan State University-sponsored trial in Flint is evaluating culturally targeted health communication to increase parental receptivity t…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Study of a Predictor for Cervix Cancer [NA]
A clinical trial evaluating a predictor for cervical cancer has been terminated.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
A Mayo Clinic-sponsored phase 1/2 trial evaluating a personalized neoantigen peptide-based vaccine in combination with pembrolizumab for adv…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Community Implementation of Urine HPV Test and Reflex DNA Methylation Test in Cervical Cancer Screening
A clinical trial update describing community implementation of a urine HPV test with reflex DNA methylation testing for cervical cancer scre…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer [NA]
A single-arm, multicenter Phase II trial evaluating camrelizumab combined with famitinib as adjuvant therapy after radical resection of cerv…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: PROton Therapy for Post Surgical Treatment of GYNecologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating proton therapy after surgery for gynecologic cancers (cervical, uterine/endometrial cancer) is currently…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
This clinical trial update describes the use of a live tumor diagnostic platform to evaluate immune checkpoint inhibitor responses across mu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers [Phase 1]
This Phase 1 clinical trial is evaluating talazoparib in combination with radiation therapy for locally recurrent gynecologic cancers, inclu…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Reduction of Hematologic Toxicity in Locally Advanced Cervical Cancers [NA]
This clinical trial update notes a study led by Institut Paoli-Calmettes aiming to reduce hematologic toxicity in locally advanced cervical …